GDK Acquires Full Marketing And Development Rights For Bexxar Worldwide

GlaxoSmithKline today announced that it has reached an agreement with Corixa Corporation to acquire worldwide rights and responsibilities related to the manufacturing, development and commercialization of the BEXXAR® therapeutic regimen... click link for more info.

Continue to GDK Acquires Full Marketing And Development Rights For Bexxar Worldwide on Medical News Today.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz